Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ionis Pharmaceutical (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,497,776
  • Shares Outstanding, K 125,520
  • Annual Sales, $ 507,670 K
  • Annual Income, $ -5,970 K
  • 36-Month Beta 2.45
  • Price/Sales 10.69
  • Price/Cash Flow 119.04
  • Price/Book 14.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.07 +12.85%
on 05/08/18
49.75 -11.38%
on 04/24/18
-6.61 (-13.04%)
since 04/23/18
3-Month
39.07 +12.85%
on 05/08/18
56.47 -21.92%
on 03/13/18
-6.94 (-13.60%)
since 02/23/18
52-Week
39.07 +12.85%
on 05/08/18
65.51 -32.70%
on 10/20/17
-1.05 (-2.33%)
since 05/23/17

Most Recent Stories

More News
Market Not Satisfied with Today's Trade Headlines

Market Not Satisfied with Today's Trade Headlines

EGC : 8.03 (+0.25%)
SLYG : 248.42 (+0.34%)
SPB : 77.67 (-1.85%)
OSK : 77.75 (-0.09%)
WRD : 26.89 (+2.48%)
BAH : 41.28 (+0.05%)
IONS : 44.09 (+0.66%)
TRI : 38.56 (-0.16%)
FLS : 43.41 (-2.65%)
BYD : 36.25 (-0.52%)
MGM : 31.60 (+0.06%)
ELY : 18.58 (-0.11%)
VST : 23.23 (+0.04%)
INCY : 66.57 (+0.02%)
CHTR : 274.09 (+2.40%)
OTEX : 34.43 (+0.70%)
AAWW : 67.90 (-0.88%)
Wired News - FDA's Advisory Committee Supports Approval of Akcea's WAYLIVRA(TM) for Treatment of Familial Chylomicronemia Syndrome

Stock Monitor: Biofrontera Post Earnings Reporting

AKCA : 22.57 (+3.15%)
IONS : 44.09 (+0.66%)
BFRA : 13.29 (-1.04%)
Look for Shares of Ionis Pharmaceut to Potentially Pullback after Yesterday's 5.84% Rise

Ionis Pharmaceut (NASDAQ:IONS) traded in a range yesterday that spanned from a low of $43.00 to a high of $45.41. Yesterday, the shares gained 5.8%, which took the trading range above the 3-day high...

IONS : 44.09 (+0.66%)
FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome

Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that the U.S. Food and Drug Administration's (FDA) Division...

AKCA : 22.57 (+3.15%)
IONS : 44.09 (+0.66%)
No Deal? No Problem for the Market

No Deal? No Problem for the Market

WPZ : 40.97 (-0.39%)
HRL : 35.82 (-0.06%)
ECHO : 27.65 (+0.55%)
DK : 51.30 (+1.30%)
SLB : 73.45 (-0.38%)
IONS : 44.09 (+0.66%)
RXN : 28.92 (-0.07%)
TRI : 38.56 (-0.16%)
MGM : 31.60 (+0.06%)
CAT : 157.74 (+0.99%)
EXEL : 20.58 (-4.55%)
CAMT : 8.31 (+0.24%)
RP : 58.50 (+0.34%)
NTLA : 25.58 (+4.07%)
Ionis (IONS) Beats Earnings & Misses Revenues in Q1

Ionis Pharmaceutical (IONS) reported positive quarter with earnings beating estimates while revenues missing the same.

IONS : 44.09 (+0.66%)
Ionis Reports First Quarter 2018 Financial Results

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the first quarter of 2018 and highlighted its recent business and pipeline successes.

IONS : 44.09 (+0.66%)
Akcea Reports Financial Results and Highlights for First Quarter 2018

-- TTR licensing transaction positions Akcea for two rare disease drug launches in 2018

AKCA : 22.57 (+3.15%)
IONS : 44.09 (+0.66%)
Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS

Akcea Therapeutics, Inc. (NASDAQ:AKCA) today announced it has expanded its global early access program (EAP) to the United States for people with familial chylomicronemia syndrome (FCS). Volanesorsen is...

AKCA : 22.57 (+3.15%)
IONS : 44.09 (+0.66%)
Apple Pulls NASDAQ, S&P into the Green

Apple Pulls NASDAQ, S&P into the Green

LSCC : 5.54 (-0.18%)
CDNS : 42.33 (+0.67%)
IONS : 44.09 (+0.66%)
DVN : 42.19 (+0.93%)
TAL : 43.73 (+2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade IONS with:

Business Summary

Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

See More

Key Turning Points

2nd Resistance Point 45.60
1st Resistance Point 44.85
Last Price 44.09
1st Support Level 43.04
2nd Support Level 41.98

See More

52-Week High 65.51
Fibonacci 61.8% 55.41
Fibonacci 50% 52.29
Fibonacci 38.2% 49.17
Last Price 44.09
52-Week Low 39.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar